Looking ahead here is our curated list (in order, by date) of the top cardiology conferences planned for 2022. 19th International Conference on Pediatrics and Pediatric Cardiology May 18-19, 2022 Location: Amsterdam, Netherlands & Online The main focus and theme for the Pediatric Cardiology 2022 conference is “Emerging interventions in Pediatric … [Read more...] about Top Cardiology Conferences 2022
Imaging
Lowering target systolic blood pressure may decrease cardiovascular events
International Society of Hypertension global hypertension guidelines1 and European Society of Cardiology guidelines2 both recommend that hypertension be diagnosed if a patient’s systolic blood pressure is ≥140 mmHg and/or their diastolic blood pressure is ≥90 mmHg. Researchers wondered if pharmaceutical intervention at a lower systolic blood pressure could further reduce the … [Read more...] about Lowering target systolic blood pressure may decrease cardiovascular events
Fractional flow reserve vs angiography-guided revascularization
Fractional flow reserve (FFR) guided revascularization did not demonstrate any benefit over angiography guided revascularization in the FLOWER-MI trial. In patients with ST-elevated myocardial infarction (STEMI) and multi-vessel disease, complete vascularization is associated with better clinical outcomes than vascularization of only the culprit lesion. Current … [Read more...] about Fractional flow reserve vs angiography-guided revascularization
Heart failure classification according to ejection fraction
Heart failure (HF) societies around the world have agreed on the following new universal definition of HF: “a clinical syndrome with symptoms and/or signs caused by a structural and/or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and/or objective evidence of pulmonary or systemic congestion.” They have also proposed a revised … [Read more...] about Heart failure classification according to ejection fraction
Top 10 Highlights of ESC Congress 2021
The European Society of Cardiology (ESC) 2021 occurred virtually this year from 27-30 August. Here is our curated list of the top 10 highlights of ESC 2021. EMPEROR-Preserved trial1 (NCT03057951): This phase 3 trial randomized 5988 adults with chronic heart failure (HF) with preserved ejection fraction (HFpEF) to take either sodium-glucose cotransporter 2 inhibitor … [Read more...] about Top 10 Highlights of ESC Congress 2021